Pegaspargase

CHEBI:CHEBI_753446

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

rxcui
213040
generic_name
Pegaspargase
product_type
HUMAN PRESCRIPTION DRUG
listing_expiration_date
20251231
route
INTRAVENOUS
dosage_form
INJECTION, SOLUTION
marketing_category
BLA
marketing_start_date
20200102
package_marketing_start_date
20200102
nui
N0000175669
pharm_class_epc
Asparagine-specific Enzyme [EPC]
pharm_class
Asparaginase [CS]
pharm_class_cs
Asparaginase [CS]
labeler_name
Servier Pharmaceuticals LLC
manufacturer_name
Servier Pharmaceuticals LLC
brand_name
ONCASPAR
brand_name_base
ONCASPAR
product_ndc
72694-954
application_number
BLA103411
spl_id
f0a8a9ab-8203-47aa-abbe-54614c201d48
active_ingredient_name
PEGASPARGASE
active_ingredient_strength
750 [iU]/mL
package_ndc
72694-954-01
package_description
1 VIAL, SINGLE-USE in 1 CARTON (72694-954-01) / 5 mL in 1 VIAL, SINGLE-USE
unii
7D96IR0PPM
spl_set_id
ac7b6a6f-6ddb-48c6-8088-d8a8e3fea6ce
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class